Login

Journal Image
Recent Patents on Anti-Infective Drug Discovery
ISSN (Print): 1574-891X
ISSN (Online): 2212-4071
VOLUME: 8
ISSUE: 2
DOI: 10.2174/1574891X113089990016      Price:  $100









A Surview of Recent Patents on Anti-Infective Therapy for Clostridium difficile

img
Author(s): Germine S. Soliman, Bechoi Saleib and Stephen J. Scholand
Pages 139-149 (11)
Abstract:
Clostridium difficile has become the most common infectious cause of healthcare-associated diarrhea, with serious morbidity, prolonged hospitalization and even death. Treatment of the disease utilizing today’s therapies does not guarantee a successful outcome. In the past decade, many new ideas and inventions have surfaced exploring different treatment strategies of Clostridium difficile associated diarrhea (CDAD). These treatments include antitoxins, novel antimicrobials, immunoglobulins and large inert synthetic compounds. In this paper, we survey of a number of representative patents issued from 2000 to the present targeting treatment of this difficult and dreaded disease.
Keywords:
Bacterial toxin, Clostridium difficile, drug target, patents.
Affiliation:
St. Mary’s Hospital Department of Internal Medicine, 56 Franklin Street, Waterbury, CT 06706 (203) 709-6000, USA.